Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma - Related Studies

Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma

This study is ongoing, but not recruiting participants.

Study NCT00082875. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Melanoma (Skin)

2	Additional conditions recognized in this trial
		Melanoma

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas

4	Interventions listed in this trial
		cilengitide

5	Sponsors listed in this trial
		M.D. Anderson Cancer Center
		National Cancer Institute (NCI)